About This Provider

About Semaglutide

During your first visit, your PlushCare doctor will review your medical history and health goals. Often, lab work is required, and they’ll send an order to your preferred lab. Once your results are available, your doctor will review them with you and discuss treatment options.If medication is prescribed, it will be sent to your pharmacy of choice. Learn more about the cost of Semaglutide and whether a prior authorization is needed in the FAQ section.

Semaglutide is a medication for chronic weight management used in conjunction with diet and exercise. When used in conjunction with lifestyle changes, this weight loss drug can be effective in helping patients lose excess weight. It comes in the form of a semaglutide injection 2.4 mg. It is manufactured by the Danish pharmaceutical company Novo Nordisk. Semaglutide is an under-the-skin, self-administered injectable prescription medicine for chronic weight management, used in addition to a reduced-calorie diet and increased exercise. It is for patients with either:

•A body mass index (BMI) of 30 kg/m2 or greater

•A BMI of 27 kg/m2 or greater with at least one weight-related ailment such as type 2 diabetes, hypertension, sleep apnea, or others.

Semaglutide uses

Semaglutide is FDA approved for weight loss in obese or overweight patients who also have another weight related condition such as type 2 diabetes, high blood pressure, high cholesterol, or others.

Weight loss

Obesity is a chronic health issue that requires long-term management and is associated with severe health complications, including heart disease, diabetes, sleep apnea, asthma, hormonal concerns for women such as PCOS, arthritis, and certain types of cancer. Losing five to ten percent of body weight can bring impactful health benefits, such as:

•Reduced risk of cardiovascular disease

•Improved energy

•Improved blood pressure, blood sugar, and cholesterol levels

On June 4, 2021, the U.S. Food and Drug Administration (FDA) approved Semaglutide for adults who suffer from obesity or are overweight.  This is the first drug for chronic weight management that has been approved since 2014.

In combination with a reduced calorie meal plan and increased physical activity, Semaglutide can be extremely effective in helping patients lose weight.

The Semaglutide Research directory

Industry Leading Providers

Explore Our Directory

Semaglutide Research

13894 South Bangerter Parkway
Draper, Utah 84020
United States of America